TriSalus Life Sciences (TLSIW) Stock Price, News & Analysis
Company Description
TriSalus Life Sciences (NASDAQ: TLSIW) is classified in the Surgical & Medical Instruments & Apparatus sector.
TLSIW has declined 64.6% over the past year. Shares last traded at $0.7789.
For FY2025, TriSalus Life Sciences reported revenue of $45.2M with net income of -$39.2M and diluted earnings per share of $-1.84. The company operates at a net profit margin of -86.9%.
This page collects what Stock Titan holds for TLSIW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
TriSalus Life Sciences (TLSIW) stock last closed at $0.7789. Over the past 12 months, the stock has lost 64.6%.
TLSIW Rankings
Latest News
SEC Filings
TriSalus Life Sciences has filed 5 recent SEC filings, including 4 Form 4, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on July 7, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TLSIW SEC filings →
Financial Highlights
TriSalus Life Sciences generated $45.2M in revenue in FY2025, retaining a 84.6% gross margin, operating income reached -$26.9M (-59.7% operating margin), and net income was -$39.2M, reflecting a -86.9% net profit margin. Diluted earnings per share stood at $-1.84. The company generated -$18.0M in operating cash flow. With a current ratio of 2.80, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in TriSalus Life Sciences (TLSIW) currently stands at 7.9 thousand shares, up 32.7% from the previous reporting period. Since July 2025, short interest has increased by 50.4%.
Days to Cover History
Days to cover for TriSalus Life Sciences (TLSIW) currently stands at 1.3 days, down 59% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 33% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 9.0 days.
TLSIW Company Profile & Sector Positioning
TriSalus Life Sciences (TLSIW) operates in the Surgical & Medical Instruments & Apparatus sector and is listed on the NASDAQ.